Published in AIDS Weekly, November 20th, 1995
Softip is the only existing needle and syringe which automatically encloses the needle in a protective micro-thin sheath before the hypodermic is withdrawn from the patient's body thereby eliminating exposure to a potentially contaminated sharp needle point.
Edward Sutherland, the company's Chief Executive Officer, stated, "Needle sales in the United States are in excess of $1 billion annually and industry analysts project the demand...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1995-11-20)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.